497 results on '"Lake, Richard"'
Search Results
2. Tretinoin improves the anti-cancer response to cyclophosphamide, in a model-selective manner
3. Mesothelioma survival prediction based on a six-gene transcriptomic signature
4. Temporally restricted activation of IFNβ signaling underlies response to immune checkpoint therapy in mice
5. Immune checkpoint therapy responders display early clonal expansion of tumor infiltrating lymphocytes
6. The MexTAg collaborative cross: host genetics affects asbestos related disease latency, but has little influence once tumours develop
7. Tumour draining lymph node-generated CD8 T cells play a role in controlling lung metastases after a primary tumour is removed but not when adjuvant immunotherapy is used
8. Bilateral murine tumor models for characterizing the response to immune checkpoint blockade
9. Consequences of fast ion driven modes in MAST
10. Voluntary exercise in mesothelioma: effects on tumour growth and treatment response in a murine model
11. Correction to: Tumour draining lymph node-generated CD8 T cells play a role in controlling lung metastases after a primary tumour is removed but not when adjuvant immunotherapy is used
12. Geldanamycin treatment does not result in anti-cancer activity in a preclinical model of orthotopic mesothelioma
13. The identification of the fouling mechanism during the crossflow filtration of a model fermentation broth
14. Bilateral murine tumor models for characterizing the response to immune checkpoint blockade
15. Supplementary Table 1 from A Molecular Diagnostic Test for Distinguishing Lung Adenocarcinoma from Malignant Mesothelioma Using Cells Collected from Pleural Effusions
16. Supplementary Tables 2-3 from A Novel SV40 TAg Transgenic Model of Asbestos-Induced Mesothelioma: Malignant Transformation Is Dose Dependent
17. Data from A Novel SV40 TAg Transgenic Model of Asbestos-Induced Mesothelioma: Malignant Transformation Is Dose Dependent
18. Activation of Immune-Mediated Tumor Cell Death by Chemotherapy
19. Effect of Chemotherapy on the Tumor Microenvironment and Anti-tumor Immunity
20. CD4+ T cells drive an inflammatory, TNF-α/IFN-rich tumor microenvironment responsive to chemotherapy
21. Unmasking tumor cell immunogenicity by chemotherapy: implications for therapy
22. Tumour associated lymphocytes in the pleural effusions of patients with mesothelioma express high levels of inhibitory receptors
23. Immunotherapeutic Approaches and Vaccination Strategies
24. Geldanamycin treatment does not result in anti-cancer activity in a preclinical model of orthotopic mesothelioma
25. Cancer chemotherapy: insights into cellular and tumor microenvironmental mechanisms of action
26. Early clonal expansion of tumor-infiltrating lymphocytes predicts response to immune checkpoint therapy
27. Comprehensive Testing of Chemotherapy and Immune Checkpoint Blockade in Preclinical Cancer Models Identifies Additive Combinations
28. Retinoic Acid Induces an IFN-Driven Inflammatory Tumour Microenvironment, Sensitizing to Immune Checkpoint Therapy
29. PPARα and PPARγ activation is associated with pleural mesothelioma invasion but therapeutic inhibition is ineffective
30. A Novel Clinical Prediction Model for Prognosis in Malignant Pleural Mesothelioma Using Decision Tree Analysis
31. Diagnosing the problem: Using a tool to identify pre-registration nursing students’ mathematical ability
32. Private specificities can dominate the humoral response to self-antigens in patients with cryptogenic fibrosing alveolitis
33. Peripheral CD8+ T cell proliferation is prognostic for patients with advanced thoracic malignancies
34. Temporally restricted activation of IFNβ signaling determines response to immune checkpoint therapy
35. The Control of Carbon Dioxide Emissions from Freight Transportation: A Case Studies Approach
36. Scientific and stakeholder evidence-based assessment:Ecosystem response to floating solar photovoltaics and implications for sustainability
37. Prioritising ecosystem opportunities and threats of floating solar photovoltaics
38. Contribution of the immune system to the chemotherapeutic response
39. Immunogenic anti-cancer chemotherapy as an emerging concept
40. Combining chemotherapy and checkpoint blockade in thoracic cancer: how to proceed?
41. Mouse models of mesothelioma: strengths, limitations and clinical translation
42. Tumor eradication after cyclophosphamide depends on concurrent depletion of regulatory T cells: a role for cycling TNFR2-expressing effector-suppressor T cells in limiting effective chemotherapy
43. Long-term exposure of mesothelial cells to SV40 and asbestos leads to malignant transformation and chemotherapy resistance
44. How to Better Understand the Influence of Host Genetics on Developing an Effective Immune Response to Thoracic Cancers
45. Malignant Pleural Effusions—A Window Into Local Anti-Tumor T Cell Immunity?
46. A National Transportation Research Organization: Alternatives and Factors
47. Immune Stimulatory Features of Classical Chemotherapy
48. List of Contributors
49. The immune function of MHC class II molecules mutated in the putative superdimer interface
50. Prioritising ecosystem opportunities and threats of floating solar photovoltaics
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.